ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 000,66
0,10%
Dow Jones
38 467,00
-0,57%
DAX
18 593,89
0,60%
Brent Oil
78,565
-2,77%
Bitcoin
69 019,46
1,88%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Boston Scientific Corporation (BSX)

  7. Boston Scientific Corporation (BSX) Actualités

BSX

Boston Scientific (BSX)

Boston Scientific Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:BSX
DateHeureSourceTitreSymboleSociété
18/05/202417h03PR Newswire (US)MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy EndpointsNYSE:BSXBoston Scientific Corporation
08/05/202422h00PR Newswire (US)Boston Scientific Elects Dr. Cheryl Pegus to Board of DirectorsNYSE:BSXBoston Scientific Corporation
24/04/202413h31IH Market NewsU.S. Futures Display Mixed Results Amid Earnings, WTI and Brent Crude Prices Dip in June Futures TradingNYSE:BSXBoston Scientific Corporation
24/04/202412h30PR Newswire (US)Boston Scientific Announces Results for First Quarter 2024NYSE:BSXBoston Scientific Corporation
08/04/202406h00PR Newswire (US)Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software ModuleNYSE:BSXBoston Scientific Corporation
01/04/202414h00PR Newswire (US)Boston Scientific Announces Conference Call Discussing First Quarter 2024 ResultsNYSE:BSXBoston Scientific Corporation
01/03/202412h55PR Newswire (US)Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated BalloonNYSE:BSXBoston Scientific Corporation
27/02/202422h15PR Newswire (US)Boston Scientific Announces Completion of €2.0 Billion Offering of Senior NotesNYSE:BSXBoston Scientific Corporation
23/02/202403h27PR Newswire (US)Boston Scientific Announces Pricing of €2.0 Billion of Senior NotesNYSE:BSXBoston Scientific Corporation
05/02/202414h00PR Newswire (US)Boston Scientific to Participate in TD Cowen's 44th Annual Health Care ConferenceNYSE:BSXBoston Scientific Corporation
31/01/202412h30PR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NYSE:BSXBoston Scientific Corporation
31/01/202412h29IH Market NewsU.S. Futures Waver Ahead of Fed Decision Amid Mixed Corporate Earnings; Oil Prices SlideNYSE:BSXBoston Scientific Corporation
31/01/202412h25PR Newswire (US)Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation SystemNYSE:BSXBoston Scientific Corporation
08/01/202422h55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NYSE:BSXBoston Scientific Corporation
08/01/202417h36Dow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNYSE:BSXBoston Scientific Corporation
08/01/202413h41Dow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNYSE:BSXBoston Scientific Corporation
08/01/202413h00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NYSE:BSXBoston Scientific Corporation
08/01/202413h00Business WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNYSE:BSXBoston Scientific Corporation
05/01/202414h00PR Newswire (US)Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 ResultsNYSE:BSXBoston Scientific Corporation
28/12/202322h00PR Newswire (US)Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial FibrillationNYSE:BSXBoston Scientific Corporation
17/11/202315h00PR Newswire (US)Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.NYSE:BSXBoston Scientific Corporation
01/11/202313h00PR Newswire (US)Boston Scientific to Participate in Stifel's 2023 Healthcare ConferenceNYSE:BSXBoston Scientific Corporation
26/10/202312h30PR Newswire (US)BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023NYSE:BSXBoston Scientific Corporation
25/10/202323h18AllPennyStocks.comMicrocap Offers Unique Opportunity for Investors In $10 Billion SCI IndustryNYSE:BSXBoston Scientific Corporation
25/10/202321h32Dow Jones NewsBoston Scientific Gets Positive Results for Heart-Failure DeviceNYSE:BSXBoston Scientific Corporation
25/10/202320h29PR Newswire (US)Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE TrialNYSE:BSXBoston Scientific Corporation
24/10/202321h18PR Newswire (US)REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS™ Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary EmbolismNYSE:BSXBoston Scientific Corporation
11/10/202317h19Dow Jones NewsBoston Scientific Down Over 6%, on Pace for Largest Percent Decrease Since May 2022 -- Data TalkNYSE:BSXBoston Scientific Corporation
02/10/202312h30PR Newswire (US)Boston Scientific Announces Conference Call Discussing Third Quarter 2023 ResultsNYSE:BSXBoston Scientific Corporation
21/09/202312h45PR Newswire (US)CVS Health appoints Michael F. Mahoney to its Board of DirectorsNYSE:BSXBoston Scientific Corporation
 Showing the most relevant articles for your search:NYSE:BSX

Dernières Valeurs Consultées

LSE
OT4
Oxford Technology 2 Vent...
EU
V546S
V546S
BIT
P45370
Bnp Paribas Issuance
COIN
SLIMEUSD
SlimeCoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés